Document Detail


Sarcomas and the conservative management of uterine fibroids: a cause for concern?
MedLine Citation:
PMID:  11065039     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The introduction of conservative management options has further increased the choices available to clinicians treating women with symptomatic uterine fibroids. However, in the absence of a tissue diagnosis, the possibility of mismanaging an underlying uterine sarcoma is still present, placing these patients at potential risk of a delayed diagnosis of this serious pathology. Evidence suggests that 1 in 250-400 women presenting with what are thought to be symptomatic fibroids, will in fact have an underlying sarcoma, making this an important clinical issue. This paper therefore reviews the methods currently available for the assessment of women in whom conservative management of symptomatic fibroids is contemplated.
Authors:
R W Dover; A J Ferrier; H W Torode
Related Documents :
20492389 - The effect of myomectomy on health-related quality of life of women with myoma uteri.
21500999 - Mediterranean climate is associated with early age at menopause and low high-density li...
19527389 - Is the surgical approach beneficial to subfertile women with symptomatic extensive aden...
21445489 - Tubal ligation: the characterization of sterilized users of a public service.
15957999 - The association of hysterectomy and menopause: a prospective cohort study.
19398089 - Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: system...
24466049 - Porphyromonas gingivalis and e-coli induce different cytokine production patterns in pr...
19246469 - Mdm2 309 polymorphism is associated with missed abortion.
24658609 - Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Australian & New Zealand journal of obstetrics & gynaecology     Volume:  40     ISSN:  0004-8666     ISO Abbreviation:  Aust N Z J Obstet Gynaecol     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2001-02-09     Completed Date:  2001-03-01     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0001027     Medline TA:  Aust N Z J Obstet Gynaecol     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  308-12     Citation Subset:  IM    
Affiliation:
Royal North Shore Hospital, St Leonards, Sydney, New South Wales, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Angiography
Biopsy, Needle
Diagnosis, Differential
Female
Gonadotropin-Releasing Hormone / administration & dosage
Humans
Leiomyoma / diagnosis*,  drug therapy,  pathology
Magnetic Resonance Imaging / methods
Middle Aged
Risk Assessment
Sarcoma / diagnosis*,  pathology,  therapy
Ultrasonography / methods
Uterine Neoplasms / diagnosis*,  drug therapy,  pathology
Chemical
Reg. No./Substance:
33515-09-2/Gonadotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The management of pulsion enterocoele with the Zacharin abdominoperineal technique (and mesh sacroco...
Next Document:  Improved patient acceptability with a transdermal drug-in-adhesive oestradiol patch.